OPGX Stock Overview
Optigenex Inc. engages in the manufacture and sale of healthy age management and beauty care products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Optigenex Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.0003 |
| 52 Week Low | US$0.0003 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.97% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| OPGX | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | -3.4% | -1.7% |
| 1Y | n/a | 6.8% | 22.9% |
Return vs Industry: Insufficient data to determine how OPGX performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how OPGX performed against the US Market.
Price Volatility
| OPGX volatility | |
|---|---|
| OPGX Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: OPGX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OPGX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Daniel Zwiren | www.optigenex.com |
Optigenex Inc. engages in the manufacture and sale of healthy age management and beauty care products. The company offers AC-11, a powdered and bioactive rainforest plant extract that helps the body to repair sun and environmental stress-related damage to DNA, and slow down the process of skin aging. It serves manufacturers, distributors, and retailers worldwide in the dietary supplement, as well as anti-aging topical skin care, cosmetic, and cosmeceutical market categories.
Optigenex Inc. Fundamentals Summary
| OPGX fundamental statistics | |
|---|---|
| Market cap | US$35.00 |
| Earnings (TTM) | -US$685.13k |
| Revenue (TTM) | US$991.25k |
0.0x
P/S Ratio0.0x
P/E RatioIs OPGX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPGX income statement (TTM) | |
|---|---|
| Revenue | US$991.25k |
| Cost of Revenue | US$364.06k |
| Gross Profit | US$627.19k |
| Other Expenses | US$1.31m |
| Earnings | -US$685.13k |
Last Reported Earnings
Dec 31, 2010
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did OPGX perform over the long term?
See historical performance and comparison